-
1
-
-
0033559299
-
Sarcoglycanopathies are responsible for 68% of severe autosomal recessive limb-girdle muscular dystrophy in the Brazilian population
-
Vainzof M, Passos-Bueno MR, Pavanello RC, Marie SK, Oliveira AS, Zatz M. Sarcoglycanopathies are responsible for 68% of severe autosomal recessive limb-girdle muscular dystrophy in the Brazilian population. J Neurol Sci 1999;164:44-49.
-
(1999)
J Neurol Sci
, vol.164
, pp. 44-49
-
-
Vainzof, M.1
Passos-Bueno, M.R.2
Pavanello, R.C.3
Marie, S.K.4
Oliveira, A.S.5
Zatz, M.6
-
2
-
-
9844227894
-
Calpain-3 deficiency causes a mild muscular dystrophy in childhood
-
Topalolu H, Dincer P, Richard I, Akcoren Z, Alehan D, Ozme S, et al. Calpain-3 deficiency causes a mild muscular dystrophy in childhood. Neuropediatrics 1997;28:212-216.
-
(1997)
Neuropediatrics
, vol.28
, pp. 212-216
-
-
Topalolu, H.1
Dincer, P.2
Richard, I.3
Akcoren, Z.4
Alehan, D.5
Ozme, S.6
-
3
-
-
16944362484
-
Multiple independent molecular etiology for limb-girdle muscular dystrophy type 2A patients from various geographical origins
-
Richard I, Brenguier L, Dincer P, Roudaut C, Bady B, Burgunder JM, et al. Multiple independent molecular etiology for limb-girdle muscular dystrophy type 2A patients from various geographical origins. Am J Hum Genet 1997;60:1128-1138.
-
(1997)
Am J Hum Genet
, vol.60
, pp. 1128-1138
-
-
Richard, I.1
Brenguier, L.2
Dincer, P.3
Roudaut, C.4
Bady, B.5
Burgunder, J.M.6
-
4
-
-
0036931942
-
Clinical variability in calpainopathy: What makes the difference?
-
de Paula F, Vainzof M, Passos-Bueno MR, de Cassia M, Pavanello R, Matioli SR, et al. Clinical variability in calpainopathy: what makes the difference? Eur J Hum Genet 2002;10:825-832.
-
(2002)
Eur J Hum Genet
, vol.10
, pp. 825-832
-
-
de Paula, F.1
Vainzof, M.2
Passos-Bueno, M.R.3
de Cassia, M.4
Pavanello, R.5
Matioli, S.R.6
-
5
-
-
4344572347
-
Calpainopathy: How broad is the spectrum of clinical variability?
-
Starling A, de Paula F, Silva H, Vainzof M, Zatz M. Calpainopathy: how broad is the spectrum of clinical variability? J Mol Neurosci 2003;21:233-236.
-
(2003)
J Mol Neurosci
, vol.21
, pp. 233-236
-
-
Starling, A.1
de Paula, F.2
Silva, H.3
Vainzof, M.4
Zatz, M.5
-
6
-
-
58949093450
-
Case of LGMD2A (calpainopathy) clinically presenting as Miyoshi distal myopathy [in Japanese]
-
Shirafuji T, Otsuka Y, Kobessho H, Minami N, Hayashi Y, Nishino I, et al. Case of LGMD2A (calpainopathy) clinically presenting as Miyoshi distal myopathy [in Japanese]. Rinsho Shinkeigaku 2008;48:651-655.
-
(2008)
Rinsho Shinkeigaku
, vol.48
, pp. 651-655
-
-
Shirafuji, T.1
Otsuka, Y.2
Kobessho, H.3
Minami, N.4
Hayashi, Y.5
Nishino, I.6
-
7
-
-
0035075146
-
The phenotype of calpainopathy: Diagnosis based on a multidisciplinary approach
-
Pollitt C, Anderson LV, Pogue R, Davison K, Pyle A, Bushby KM. The phenotype of calpainopathy: diagnosis based on a multidisciplinary approach. Neuromuscul Disord 2001;11:287-296.
-
(2001)
Neuromuscul Disord
, vol.11
, pp. 287-296
-
-
Pollitt, C.1
Anderson, L.V.2
Pogue, R.3
Davison, K.4
Pyle, A.5
Bushby, K.M.6
-
8
-
-
0032132736
-
Pseudometabolic expression and phenotypic variability of calpain deficiency in two siblings
-
Penisson-Besnier I, Richard I, Dubas F, Beckmann JS, Fardeau M. Pseudometabolic expression and phenotypic variability of calpain deficiency in two siblings. Muscle Nerve 1998;21:1078-1080.
-
(1998)
Muscle Nerve
, vol.21
, pp. 1078-1080
-
-
Penisson-Besnier, I.1
Richard, I.2
Dubas, F.3
Beckmann, J.S.4
Fardeau, M.5
-
9
-
-
33644502934
-
Analysis of histopathologic and molecular pathologic findings in Czech LGMD2A patients
-
Hermanova M, Zapletalova E, Sedlackova J, Chrobakova T, Letocha O, Kroupova I, et al. Analysis of histopathologic and molecular pathologic findings in Czech LGMD2A patients. Muscle Nerve 2006;33: 424-432.
-
(2006)
Muscle Nerve
, vol.33
, pp. 424-432
-
-
Hermanova, M.1
Zapletalova, E.2
Sedlackova, J.3
Chrobakova, T.4
Letocha, O.5
Kroupova, I.6
-
10
-
-
3042824625
-
Molecular diagnosis in LGMD2A: Mutation analysis or protein testing?
-
Fanin M, Fulizio L, Nascimbeni AC, Spinazzi M, Piluso G, Ventriglia VM, et al. Molecular diagnosis in LGMD2A: mutation analysis or protein testing? Hum Mutat 2004;24:52-62.
-
(2004)
Hum Mutat
, vol.24
, pp. 52-62
-
-
Fanin, M.1
Fulizio, L.2
Nascimbeni, A.C.3
Spinazzi, M.4
Piluso, G.5
Ventriglia, V.M.6
-
11
-
-
0034893933
-
Calpain-3 gene mutations: Genetic and clinico-pathologic findings in limb-girdle muscular dystrophy
-
Chae J, Minami N, Jin Y, Nakagawa M, Murayama K, Igarashi F, et al. Calpain-3 gene mutations: genetic and clinico-pathologic findings in limb-girdle muscular dystrophy. Neuromuscul Disord 2001;11:547-555.
-
(2001)
Neuromuscul Disord
, vol.11
, pp. 547-555
-
-
Chae, J.1
Minami, N.2
Jin, Y.3
Nakagawa, M.4
Murayama, K.5
Igarashi, F.6
-
12
-
-
20144389936
-
LGMD2A: Genotype-phenotype correlations based on a large mutational survey on the calpain-3 gene
-
Saenz A, Leturcq F, Cobo AM, Poza JJ, Ferrer X, Otaegui D, et al. LGMD2A: genotype-phenotype correlations based on a large mutational survey on the calpain-3 gene. Brain 2005;128:732-742.
-
(2005)
Brain
, vol.128
, pp. 732-742
-
-
Saenz, A.1
Leturcq, F.2
Cobo, A.M.3
Poza, J.J.4
Ferrer, X.5
Otaegui, D.6
-
13
-
-
0002670572
-
The clinical examination of voluntary muscles
-
In: Walton JN, editor, 3rd ed. Edinburgh: Churchill Livingtone
-
Gardner-Medwin D, Walton JN. The clinical examination of voluntary muscles. In: Walton JN, editor. Disorders of voluntary muscles, 3rd ed. Edinburgh: Churchill Livingtone; 1974. p 517-560.
-
(1974)
Disorders of Voluntary Muscles
, pp. 517-560
-
-
Gardner-Medwin, D.1
Walton, J.N.2
-
14
-
-
0028905205
-
Mutations in the proteolytic enzyme calpain-3 cause limb-girdle muscular dystrophy type 2A
-
Richard I, Broux O, Allamand V, Fougerousse F, Chiannikulchai N, Bourg N, et al. Mutations in the proteolytic enzyme calpain-3 cause limb-girdle muscular dystrophy type 2A. Cell 1995;81:27-40.
-
(1995)
Cell
, vol.81
, pp. 27-40
-
-
Richard, I.1
Broux, O.2
Allamand, V.3
Fougerousse, F.4
Chiannikulchai, N.5
Bourg, N.6
-
15
-
-
0031662389
-
Characterization of monoclonal antibodies to calpain-3 and protein expression in muscle from patients with limb-girdle muscular dystrophy type 2A
-
Anderson LV, Davison K, Moss JA, Richard I, Fardeau M, Tome ́ FM, et al. Characterization of monoclonal antibodies to calpain-3 and protein expression in muscle from patients with limb-girdle muscular dystrophy type 2A. Am J Pathol 1998;153:1169-1179.
-
(1998)
Am J Pathol
, vol.153
, pp. 1169-1179
-
-
Anderson, L.V.1
Davison, K.2
Moss, J.A.3
Richard, I.4
Fardeau, M.5
Tome ́, F.M.6
-
16
-
-
0032479445
-
Functional defects of a muscle-specific calpain, p94, caused by mutations associated with limb-girdle muscular dystrophy type 2A
-
Ono Y, Shimada H, Sorimachi H, Richard I, Saido TC, Beckmann JS, et al. Functional defects of a muscle-specific calpain, p94, caused by mutations associated with limb-girdle muscular dystrophy type 2A. J Biol Chem 1998;273:17073-17078.
-
(1998)
J Biol Chem
, vol.273
, pp. 17073-17078
-
-
Ono, Y.1
Shimada, H.2
Sorimachi, H.3
Richard, I.4
Saido, T.C.5
Beckmann, J.S.6
-
17
-
-
33745817771
-
Suppressed disassembly of autolyzing p94/CAPN3 by N2A connectin/titin in a genetic reporter system
-
Ono Y, Torii F, Ojima K, Doi N, Yoshioka K, Kawabata Y, et al. Suppressed disassembly of autolyzing p94/CAPN3 by N2A connectin/titin in a genetic reporter system. J Biol Chem 2006;281: 18519-18531.
-
(2006)
J Biol Chem
, vol.281
, pp. 18519-18531
-
-
Ono, Y.1
Torii, F.2
Ojima, K.3
Doi, N.4
Yoshioka, K.5
Kawabata, Y.6
-
18
-
-
0027365768
-
Spatial resolution of fodrin proteolysis in postischemic brain
-
Saido TC, Yokota M, Nagao S, Yamaura I, Tani E, Tsuchiya T, et al. Spatial resolution of fodrin proteolysis in postischemic brain. J Biol Chem 1993;268:25239-25243.
-
(1993)
J Biol Chem
, vol.268
, pp. 25239-25243
-
-
Saido, T.C.1
Yokota, M.2
Nagao, S.3
Yamaura, I.4
Tani, E.5
Tsuchiya, T.6
-
19
-
-
0027276561
-
Muscle-specific calpain, p94, is degraded by autolysis immediately after translation, resulting in disappearance from muscle
-
Sorimachi H, Toyama-Sorimachi N, Saido TC, Kawasaki H, Sugita H, Miyasaka M, et al. Muscle-specific calpain, p94, is degraded by autolysis immediately after translation, resulting in disappearance from muscle. J Biol Chem 1993;268:10593-10605.
-
(1993)
J Biol Chem
, vol.268
, pp. 10593-10605
-
-
Sorimachi, H.1
Toyama-Sorimachi, N.2
Saido, T.C.3
Kawasaki, H.4
Sugita, H.5
Miyasaka, M.6
-
20
-
-
56749143763
-
Concerted multi-pronged attack by calpastatin to occlude the catalytic cleft of heterodimeric calpains
-
Moldoveanu T, Gehring K, Green DR. Concerted multi-pronged attack by calpastatin to occlude the catalytic cleft of heterodimeric calpains. Nature 2008;456:404-408.
-
(2008)
Nature
, vol.456
, pp. 404-408
-
-
Moldoveanu, T.1
Gehring, K.2
Green, D.R.3
-
21
-
-
56749172400
-
Calcium-bound structure of calpain and its mechanism of inhibition by calpastatin
-
Hanna RA, Campbell RL, Davies PL. Calcium-bound structure of calpain and its mechanism of inhibition by calpastatin. Nature 2008; 456:409-412.
-
(2008)
Nature
, vol.456
, pp. 409-412
-
-
Hanna, R.A.1
Campbell, R.L.2
Davies, P.L.3
-
23
-
-
47249105570
-
Multiple molecular interactions implicate the connectin/titin N2A region as a modulating scaffold for p94/calpain-3 activity in skeletal muscle
-
Hayashi C, Ono Y, Doi N, Kitamura F, Tagami M, Mineki R, et al. Multiple molecular interactions implicate the connectin/titin N2A region as a modulating scaffold for p94/calpain-3 activity in skeletal muscle. J Biol Chem 2008;283:14801-14814.
-
(2008)
J Biol Chem
, vol.283
, pp. 14801-14814
-
-
Hayashi, C.1
Ono, Y.2
Doi, N.3
Kitamura, F.4
Tagami, M.5
Mineki, R.6
-
24
-
-
0344629442
-
Calpain-3 is activated through autolysis within the active site and lyses sarcomeric and sarcolemmal components
-
Taveau M, Bourg N, Sillon G, Roudaut C, Bartoli M, Richard I. Calpain-3 is activated through autolysis within the active site and lyses sarcomeric and sarcolemmal components. Mol Cell Biol 2003;23: 9127-9135.
-
(2003)
Mol Cell Biol
, vol.23
, pp. 9127-9135
-
-
Taveau, M.1
Bourg, N.2
Sillon, G.3
Roudaut, C.4
Bartoli, M.5
Richard, I.6
-
25
-
-
12944300453
-
The crystal structure of calcium-free human m-calpain suggests an electrostatic switch mechanism for activation by calcium
-
Strobl S, Fernandez-Catalan C, Braun M, Huber R, Masumoto H, Nakagawa K, et al. The crystal structure of calcium-free human m-calpain suggests an electrostatic switch mechanism for activation by calcium. Proc Natl Acad Sci USA 2000;97:588-592.
-
(2000)
Proc Natl Acad Sci USA
, vol.97
, pp. 588-592
-
-
Strobl, S.1
Fernandez-Catalan, C.2
Braun, M.3
Huber, R.4
Masumoto, H.5
Nakagawa, K.6
-
26
-
-
54449100812
-
Novel role of calpain-3 in the triad-associated protein complex regulating calcium release in skeletal muscle
-
Kramerova I, Kudryashova E, Wu B, Ottenheijm C, Granzier H, Spencer MJ. Novel role of calpain-3 in the triad-associated protein complex regulating calcium release in skeletal muscle. Hum Mol Genet 2008;17:3271-3280.
-
(2008)
Hum Mol Genet
, vol.17
, pp. 3271-3280
-
-
Kramerova, I.1
Kudryashova, E.2
Wu, B.3
Ottenheijm, C.4
Granzier, H.5
Spencer, M.J.6
-
27
-
-
79952451731
-
Non-proteolytic functions of calpain-3 in sarcoplasmic reticulum in skeletal muscles
-
Ojima K, Ono Y, Ottenheijm C, Hata S, Suzuki H, Granzier H, et al. Non-proteolytic functions of calpain-3 in sarcoplasmic reticulum in skeletal muscles. J Mol Biol 2011;407:439-449.
-
(2011)
J Mol Biol
, vol.407
, pp. 439-449
-
-
Ojima, K.1
Ono, Y.2
Ottenheijm, C.3
Hata, S.4
Suzuki, H.5
Granzier, H.6
|